The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Disease Eradication/*organization & administration ; Disease Outbreaks/*prevention & control ; Health Promotion/*methods ; Immunization Programs/*organization & administration ; Immunization Programs/*statistics & numerical data ; Poliomyelitis/*prevention & control ; Vaccination/*statistics & numerical data; Developing Countries ; Disease Eradication/statistics & numerical data ; Health Promotion/statistics & numerical data ; Humans ; Kenya ; Population Surveillance
    • Abstract:
      Background: In 1988, the 41 st World Health Assembly (WHA) marked the launch of the Global Polio Eradication Initiative (GPEI) for the eradication of polio. A key component of the GPEI has been the development and deployment of a skilled workforce to implement eradication activities. In 1989, the Stop Transmission of Polio (STOP) was initiated to address skilled human resource gaps and strengthen poliovirus surveillance. This paper describes the role of the STOP 52 team in technical capacity building and health system strengthening in the implementation of polio eradication strategies in Kenya following the outbreak of Circulating Vaccine-derived Poliovirus type 2 (cVDPV2).
      Methods: Overview of the STOP program, deployment, and the modality of support are described. Descriptive analysis was conducted using data collected by the STOP 52 team during integrated supportive supervisory visits conducted from July 2018 to September 2019. Analyses were carried out using Epi-Info statistical software (Version 7.0) and maps were developed using Quantum Geographic Information System (Q-GIS) (version 3.12.0).
      Results: The STOP 52 team supportively supervised 870 health facilities on Expanded Program on Immunization (EPI), and Acute Flaccid Paralysis (AFP) and other Vaccine-Preventable Diseases (VPDs) surveillance in 16 (34.1%) of the 47 counties during the study period. AFP surveillance was conducted in all health facilities supervised leading to the detection and investigation of 11 unreported AFP cases. The STOP 52 team, as part of the outbreak response, provided technical support to five successive rounds of polio Supplementary Immunization Activities (SIAs) conducted during the study period. Moreover, in addressing programmatic data needs, the STOP 52 Data Manager played a valuable role in enhancing the quality and use of data for evidence-based planning and decision-making. The STOP 52 team contributed to the development of operational plans, guidelines and training manuals, and participated in the delivery of various Training of Trainers (TOT) and On-the-Job Training (OJT) on EPI, AFP and other VPDs surveillance including data management.
      Conclusion: The STOP 52 team has contributed to polio eradication efforts in Kenya by enhancing AFP and other VPDs surveillance, supporting polio SIAs, strengthening EPI, use of quality EPI, AFP and other VPDs data, and capacity building of Frontline Health Workers (FLWs). The use of Open Data Kit (ODK) technology during supportive supervision, and AFP and other VPDs surveillance was found to be advantageous. A national STOP program should be modeled to produce a homegrown workforce to ensure the availability of more sustainable technical support for polio eradication efforts in Kenya and possibly other polio-affected countries.
    • References:
      MMWR Morb Mortal Wkly Rep. 2013 May 3;62(17):335-8. (PMID: 23636027)
      MMWR Morb Mortal Wkly Rep. 2019 Apr 05;68(13):312-318. (PMID: 30946737)
      Pan Afr Med J. 2017 Jun 22;27(Suppl 3):20. (PMID: 29296155)
      N Engl J Med. 2011 Jun 16;364(24):2273-5. (PMID: 21675884)
      J Infect Dis. 2017 Jul 1;216(suppl_1):S316-S323. (PMID: 28838200)
      Am J Trop Med Hyg. 2019 Oct;101(4_Suppl):45-51. (PMID: 31760977)
      JMIR Mhealth Uhealth. 2017 Nov 30;5(11):e171. (PMID: 29191798)
      JMIR Mhealth Uhealth. 2015 Jan 14;3(1):e4. (PMID: 25589367)
      BMC Public Health. 2018 Dec 13;18(Suppl 4):1317. (PMID: 30541512)
      JAMA. 2004 Jun 2;291(21):2623-7. (PMID: 15173154)
      MMWR Morb Mortal Wkly Rep. 2017 Nov 24;66(46):1276-1280. (PMID: 29166363)
      Am J Trop Med Hyg. 2019 Oct;101(4_Suppl):100-106. (PMID: 31760979)
      J Infect Dis. 2017 Jul 1;216(suppl_1):S362-S367. (PMID: 28838163)
      MMWR Morb Mortal Wkly Rep. 2013 Jun 21;62(24):501-3. (PMID: 23784015)
      J Infect Dis. 2014 Nov 1;210 Suppl 1:S5-15. (PMID: 25316873)
      Lancet. 2003 Sep 27;362(9389):1022-7. (PMID: 14522532)
      J Infect Dis. 2016 May 1;213 Suppl 3:S96-100. (PMID: 26823334)
    • Grant Information:
      001 International WHO_ World Health Organization
    • Contributed Indexing:
      Keywords: Human resource; Immunization; Polio; Stop Transmission of Polio (STOP); Surveillance; Vaccine-Preventable Diseases (VPDs)
    • Publication Date:
      Date Created: 20200716 Date Completed: 20201116 Latest Revision: 20210110
    • Publication Date:
      20240829
    • Accession Number:
      PMC7362661
    • Accession Number:
      10.1186/s12889-020-09196-1
    • Accession Number:
      32664859